FDA Clearance Tracker · P100030-S018
Preveleak Surgical Sealant, Preveleak I 0-pack delivery tips
Last checked: Nov 20, 2026Latest source record: Nov 29, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Nov 29, 2023
Approved
Time to decision
29 days
Received Oct 31, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P100030-S018
- Device name
- Preveleak Surgical Sealant, Preveleak I 0-pack delivery tips
- Applicant
- Baxter Healthcare Corporation
- Applicant location
- Deerfield Lake, IL
- Received
- Oct 31, 2023
- Decided
- Nov 29, 2023
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P100030
Device type
- Device type
- Sealant, polymerizing (NBE)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for a manufacturing site located at Hayward, California to manufacture the Preveleak Sealant, 4mL and delivery tips.
Source documents
Other decisions for Baxter Healthcare Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K251745 · Decided Dec 16, 2025 · 193 days after receipt
Device type: Blood Pressure Cuff (DXQ) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.